Title |
NF-κB Pathways in the Pathogenesis of Multiple Sclerosis and the Therapeutic Implications
|
---|---|
Published in |
Frontiers in Molecular Neuroscience, September 2016
|
DOI | 10.3389/fnmol.2016.00084 |
Pubmed ID | |
Authors |
Saskia M. Leibowitz, Jun Yan |
Abstract |
Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling pathways are involved in cell immune responses, apoptosis and infections. In multiple sclerosis (MS), NF-κB pathways are changed, leading to increased levels of NF-κB activation in cells. This may indicate a key role for NF-κB in MS pathogenesis. NF-κB signaling is complex, with many elements involved in its activation and regulation. Interestingly, current MS treatments are found to be directly or indirectly linked to NF-κB pathways and act to adjust the innate and adaptive immune system in patients. In this review, we will first focus on the intricacies of NF-κB signaling, including the activating pathways and regulatory elements. Next, we will theorize about the role of NF-κB in MS pathogenesis, based on current research findings, and discuss some of the associated therapeutic implications. Lastly, we will review four new MS treatments which interrupt NF-κB pathways-fingolimod, teriflunomide, dimethyl fumarate (DMF) and laquinimod (LAQ)-and explain their mechanisms, and the possible strategy for MS treatments in the future. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
Switzerland | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 100 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 15 | 15% |
Student > Ph. D. Student | 13 | 13% |
Student > Master | 12 | 12% |
Student > Bachelor | 12 | 12% |
Student > Doctoral Student | 5 | 5% |
Other | 17 | 17% |
Unknown | 26 | 26% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 16 | 16% |
Neuroscience | 16 | 16% |
Medicine and Dentistry | 12 | 12% |
Agricultural and Biological Sciences | 11 | 11% |
Immunology and Microbiology | 4 | 4% |
Other | 10 | 10% |
Unknown | 31 | 31% |